Genomic software and services provider PierianDx plans to expand its unified sample-to-report software platform capabilities through the acquisition of genomics software company Tute Genomics.

"Danaher Corporation will acquire Phenomenex as part of a definitive agreement signed between the two."

Pursuant to the acquisition, PierianDx will be responsible for maintaining Tute Genomics solution until spring 2017, before the software platforms become fully integrated into CGW 6.0.

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

Danaher Corporation will acquire Phenomenex as part of a definitive agreement signed between the two.

Following the completion of the acquisition, Phenomenex will retain its brand and operate at the existing locations with its existing workforce.

The acquisition allows Danaher to improve its Danaher Business System (DBS) tools and Phenomenex to expand its research and development (R&D) capabilities.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

Pharmaceutical Technology Excellence Awards - Nominations Closed

Nominations are now closed for the Pharmaceutical Technology Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact.

Excellence in Action
Awarded the 2025 Pharmaceutical Technology Excellence Award for Business Expansion in Integrated Manufacturing, Upperton Pharma Solutions is rapidly expanding its UK GMP and sterile manufacturing footprint. Find out how Upperton’s integrated CDMO model helps pharma companies move from early development to clinical and niche commercial supply with fewer handovers and faster timelines.

Discover the Impact